Corey S Goodman's Net Worth

$390 Million

Estimate Recalculated Mar 1, 2024 01:29PM EST

Who is Corey S Goodman?

Corey S Goodman has an estimated net worth of $390 Million. This is based on reported shares across multiple companies, which include PFIZER INC, Checkmate Pharmaceuticals, Inc., RENOVIS INC, RayzeBio, Inc., Ventyx Biosciences, Inc., ALX ONCOLOGY HOLDINGS INC, Akero Therapeutics, Inc., Metacrine, Inc., IMPEL NEUROPHARMA INC, Elevation Oncology, Inc., and PRECISION BIOSCIENCES INC.

SEC CIK

Corey S Goodman's CIK is 0001278411

Past Insider Trading and Trends

2008 was Corey S Goodman's most active year for acquiring shares with 22 total transactions. Corey S Goodman's most active month to acquire stocks was the month of May. 2006 was Corey S Goodman's most active year for disposing of shares, totalling 200 transactions. Corey S Goodman's most active month to dispose stocks was the month of March. 2020 saw Corey S Goodman paying a total of $22,140,000.00 for 14,795,091 shares, this is the most they've acquired in one year. In 2020 Corey S Goodman cashed out on 35,822,664 shares for a total of $20,743,395.94, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PFIZER INC (PFE) Snapshot price: $27.5475

Senior Vice President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Apr 30
Form 4
0
0
Apr 15
Form 4
0
0
Mar 31
Form 4
0
0
Mar 13
Form 4
+170.79%
51.87K
82.23K
Feb 26
Form 4
0
0
Dec 31
Form 4
0
0
Dec 15
Form 4
0
0
Nov 26
Form 4
0
0
Nov 14
Form 4
0
0
Oct 31
Form 4
0
0
Oct 15
Form 4
0
0
Sep 30
Form 4
0
0
Sep 15
Form 4
0
0
Aug 29
Form 4
0
0
Aug 15
Form 4
0
0
Jul 31
Form 4
0
0
Jul 15
Form 4
0
0
Jun 30
Form 4
0
0
Jun 13
Form 4
0
0
May 30
Form 4
0
0
May 15
Form 4
0
0
Apr 30
Form 4
0
0
Apr 15
Form 4
0
0
Mar 31
Form 4
0
0
Mar 14
Form 4
+587.59%
24.14K
28.25K
Feb 28
Form 4
4K
4K
Oct 31
Form 3
0
0
No matching records found

Checkmate Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.75%
-131.65K
$10.45
-$1,375,564.42
2.16M
May 13 - May 16
Form 4
-6.57%
-160.90K
$10.39
-$1,671,823.84
2.29M
May 10 - May 12
Form 4
-3.42%
-86.68K
$10.37
-$898,920.56
2.45M
May 5 - May 9
Form 4
-9.65%
-270.68K
$10.38
-$2,809,332.35
2.54M
May 2 - May 4
Form 4
-6.34%
-190.03K
$10.38
-$1,972,578.78
2.81M
Apr 27 - Apr 29
Form 4
-4.15%
-129.78K
$10.39
-$1,347,796.50
3M
Apr 22 - Apr 26
Form 4
-14.91%
-547.73K
$10.41
-$5,700,491.17
3.13M
Apr 19 - Apr 21
Form 4
3.67M
$15.00
3.67M
Aug 11
Form 3
0
0
No matching records found

RENOVIS INC No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-558.22K
0
May 2
Form 4
-12.29%
-38.23K
$2.40
-$91,744.80
272.82K
Feb 8
Form 4
+4,572.82%
395K
403.64K
Jan 26
Form 4
0
0
Jan 4
Form 4
-0.96%
-1.85K
$3.09
-$5,725.27
191.96K
Scheduled
Dec 18
Form 4
-0.95%
-1.85K
$3.38
-$6,262.17
193.81K
Scheduled
Nov 20
Form 4
-18.92%
-45.65K
$3.64
-$166,206.22
195.66K
Scheduled
Oct 26 - Oct 27
Form 4
-2.43%
-6.00K
$13.62
-$81,693.76
241.31K
Scheduled
Oct 2
Form 4
-2.37%
-6.00K
$14.74
-$88,448.00
247.31K
Scheduled
Sep 1
Form 4
-2.31%
-6.00K
$12.34
-$74,021.28
253.31K
Scheduled
Aug 1
Form 4
-2.26%
-6.00K
$15.33
-$91,965.79
259.31K
Scheduled
Jul 3
Form 4
-2.21%
-6.00K
$16.27
-$97,613.81
265.31K
Scheduled
Jun 1
Form 4
-2.16%
-6.00K
$17.57
-$105,406.08
271.31K
Scheduled
May 1
Form 4
+21.65%
49.35K
$1.02
$50,563.40
277.31K
Apr 12
Form 4
-5.20%
-12.50K
$20.28
-$253,560.00
227.96K
Scheduled
Apr 6
Form 4
-3.61%
-9.00K
$20.77
-$186,961.52
240.46K
Scheduled
Apr 3
Form 4
-5.28%
-12.50K
$21.97
-$274,597.00
224.46K
Scheduled
Mar 6
Form 4
-3.66%
-9.00K
$21.96
-$197,682.78
236.96K
Scheduled
Mar 1
Form 4
-4.84%
-12.50K
$20.18
-$252,258.04
245.96K
Scheduled
Feb 6
Form 4
-3.37%
-9.00K
$20.99
-$188,911.74
258.46K
Scheduled
Feb 1
Form 4
-1.11%
-3.00K
$20.00
-$60,000.00
267.46K
Scheduled
Jan 25 - Jan 26
Form 4
-4.42%
-12.50K
$19.00
-$237,500.00
270.46K
Scheduled
Jan 16 - Jan 18
Form 4
-2.08%
-6.00K
$15.18
-$91,059.50
282.96K
Scheduled
Jan 3
Form 4
-2.03%
-6.00K
$15.85
-$95,123.00
288.96K
Scheduled
Dec 1
Form 4
-1.99%
-6.00K
$13.83
-$82,998.55
294.96K
Scheduled
Nov 1
Form 4
-1.95%
-6.00K
$13.49
-$80,961.00
300.96K
Scheduled
Oct 3
Form 4
-3.16%
-10.00K
306.96K
Sep 8
Form 4
-1.86%
-6.00K
$13.27
-$79,599.00
316.96K
Scheduled
Sep 1
Form 4
-1.82%
-6.00K
$15.21
-$91,250.79
322.96K
Scheduled
Aug 1
Form 4
-1.79%
-6.00K
$15.04
-$90,221.45
328.96K
Scheduled
Jul 1
Form 4
+854.41%
25K
$0.81
$20,250.00
27.93K
Jun 3
Form 4
-1.76%
-6.00K
$13.52
-$81,121.84
334.96K
Scheduled
Jun 1
Form 4
-1.73%
-6.00K
$14.73
-$88,380.00
340.96K
Scheduled
May 4
Form 4
0
0
Feb 9
Form 4
-1.70%
-6.00K
$11.93
-$71,592.00
346.96K
Feb 1
Form 4
-1.67%
-6.00K
$13.94
-$83,629.04
352.96K
Jan 3
Form 4
-1.64%
-6.00K
$14.19
-$85,161.00
358.96K
Dec 1
Form 4
-1.62%
-6.00K
$13.77
-$82,635.25
364.96K
Nov 24
Form 4
+0.84%
3.09K
370.96K
Feb 10
Form 3
0
0
No matching records found

RayzeBio, Inc. (RYZB) Snapshot price: $62.18

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
5.16M
5.16M
Sep 19
Form 3
0
0
No matching records found

Ventyx Biosciences, Inc. (VTYX) Snapshot price: $2.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 9
Form 4
4M
$16.00
4M
Oct 25
Form 3
0
0
No matching records found